Rep. Ro Khanna reported roughly $83,000 in purchases of medical device giant SYK in February, according to newly filed congressional disclosures, adding to the California Democrat’s long history of active trading activity.
The transactions, made across two separate filings within a week, show buying in Stryker Corporation — a $128.9 billion medical technology company whose products range from orthopedic implants to surgical robotics systems used widely in hospitals and outpatient surgery centers.
Stryker shares recently traded around $336.77, and the company is often viewed by investors as a bellwether for procedure volumes and hospital capital spending. Demand for joint replacements, trauma equipment, and surgical tools has helped make the firm one of the largest players in the global medical device market.
Details of the February purchases
The disclosure shows two purchases made during the same week in February:
- Feb. 17, 2026: Buy of $1,000–$15,000 in Stryker shares (owner: spouse)
- Feb. 24, 2026: Buy of $50,000–$100,000 in Stryker shares (owner: DC)
Using midpoint estimates, the combined value of the trades is approximately $83,000. Congressional financial disclosures report transactions in broad dollar ranges rather than exact amounts.
The second purchase represents the bulk of the position, suggesting a more substantial allocation to the healthcare equipment maker late in the month.
A widely held congressional stock
Stryker is not an uncommon name in congressional portfolios. According to trade disclosures, 31 lawmakers have reported transactions involving the stock in recent years, making it one of the more frequently traded medical device companies on Capitol Hill.
The company’s scale and exposure to long-term demographic trends — particularly aging populations and rising surgical volumes — have made it a staple holding for institutional investors and lawmakers alike.
Unlike lawmakers who sit on health policy committees, Khanna does not directly oversee the medical device industry through his committee assignments. He serves on the House Committee on Armed Services and the House Committee on Oversight and Government Reform, as well as the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party.
Those panels focus primarily on defense policy, federal oversight, and technology competition rather than healthcare regulation.
Active trading history
Khanna has been among the more active traders in Congress. Disclosure data shows roughly 19,625 career trades reported across accounts associated with the lawmaker and his household.
Members of Congress are permitted to buy and sell individual stocks as long as they disclose the transactions under the STOCK Act, which requires trades to be reported within 45 days.
The February purchases add Stryker to the list of healthcare-related holdings appearing in recent filings. Investors and transparency watchdogs continue to monitor latest congressional trades as lawmakers balance personal investing with their roles shaping federal policy.